Lisa Chang

As interest in medical uses of cannabis constituents grows, researchers are closely examining how cannabidiol (CBD), a naturally occurring compound in plants, impacts health, especially regarding cancer and inflammatory diseases. CBD is recognized for its antidepressant, anxiolytic, and antiepileptic properties, and now, scientists are exploring its ability to regulate essential cellular functions like autophagy and … Read more

In a promising development for lung cancer treatment, a recent study has unveiled that combining low doses of the chemotherapy drug dasatinib with cannabidiol (CBD), a compound derived from cannabis, significantly enhances the efficacy of cancer therapy while reducing its side effects. This groundbreaking research could pave the way for new treatment protocols that are … Read more

In a pivotal study, researchers have identified a promising new treatment approach for glioblastoma (GBM), an aggressive brain cancer with limited effective treatments and a typically poor prognosis. The research focuses on the potential therapeutic effects of inhalant cannabidiol (CBD), a non-psychoactive compound derived from cannabis. Glioblastoma is notoriously challenging due to its fast growth … Read more

In recent research that could redefine treatment approaches for schizophrenia, cannabidiol (CBD), a non-psychoactive component of cannabis, is being highlighted for its potential to manage symptoms associated with the mental health disorder. Schizophrenia, which affects 1% of adults globally, has one of the highest mortality rates among psychiatric conditions, underscoring the urgency for more effective … Read more

In a groundbreaking study, researchers have revealed that CBD may offer new hope in the fight against liver fibrosis. This condition, which can progress to severe liver diseases such as cirrhosis and hepatocellular carcinoma, poses a significant public health challenge. The study utilized a mouse model with liver fibrosis induced by carbon tetrachloride (CCl4), a … Read more

Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, continues to capture the interest of the medical community due to its wide-ranging potential therapeutic benefits. Notably, recent research has shown its efficacy in managing certain types of drug-resistant epilepsies and has hinted at potential benefits for anxiety, chronic pain, and inflammatory disorders based on animal studies. … Read more

Researchers are delving into the potential of cannabis to treat cancer, spurred by initial findings that suggest cannabinoids—active compounds in cannabis—may possess anti-cancer properties. However, translating these properties into effective treatments presents significant challenges, according to experts in the field. Cannabis contains over 100 different cannabinoids, with tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most … Read more

A recent study analyzing data from the 2021 Behavioral Risk Factor Surveillance System (BRFSS) has found that non-medical cannabis use may be associated with a reduced risk of subjective cognitive decline (SCD). The study, which included data from over 4,700 U.S. adults aged 45 and older, sought to uncover the relationship between different dimensions of … Read more